Cure Huntington's Disease Initiative Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2005
NCT00271596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Cure Huntington's Disease Initiative (CHDI)

Active Ingredients

Drugs in Phase 2 Trials (1)

citalopram (celexa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chorea (Phase 2)

Huntington Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1